View in EDS

Mutation-centric kinase drug repurposing for rare cancers.

Saved in:
Bibliographic Details
Title: Mutation-centric kinase drug repurposing for rare cancers.
Authors: Chan M; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ma H; Reaction Biology, Malvern, PA, USA., Subbiah V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Gujral TS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA. tgujral@fredhutch.org.
Source: Nature reviews. Cancer [Nat Rev Cancer] 2026 Jul; Vol. 26 (7), pp. 473-474.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42225836
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mutation-centric kinase drug repurposing for rare cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chan+M%22">Chan M</searchLink>; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Ma+H%22">Ma H</searchLink>; Reaction Biology, Malvern, PA, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gujral+TS%22">Gujral TS</searchLink>; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA. tgujral@fredhutch.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101124168%22">Nature reviews. Cancer</searchLink> [Nat Rev Cancer] 2026 Jul; Vol. 26 (7), pp. 473-474.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101124168 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-1768 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221474175X%22">1474175X </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Cancer <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42225836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41568-026-00944-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 473
    Titles:
      – TitleFull: Mutation-centric kinase drug repurposing for rare cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan M
      – PersonEntity:
          Name:
            NameFull: Ma H
      – PersonEntity:
          Name:
            NameFull: Subbiah V
      – PersonEntity:
          Name:
            NameFull: Gujral TS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1474-1768
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nature reviews. Cancer
              Type: main
ResultId 1